DROSTANOLONE

DROSTANOLONE

Drostanolone (Masterone) is medically prescribed as an  anti-estrogenic therapy for the treatment of advanced inoperable breast cancer in postmenopausal women. It was originally manufactured under pharmaceutical production by Lilly/Syntex during the 1970s. The drug is an injectable AAS derived from dihydrotestosterone (DHT). It

METHENOLONE

METHENOLONE

Methenolone is a non aromatized anabolic steroid with a low androgenic index. It is considered as a derivative of dihydrotestosterone (DHT). As a result, it does not lead to any water retention or gynecomastia (E2- beta estradiol elevation). Therefore, methenolone enanthate-acetate are

METHYLTRIENOLONE (M3)

METHYLTRIENOLONE (M3)

Methyltrienolone (M3) is perhaps the most hepatotoxic oral, among the 17 alkylated AAS. It was initially medically used against advanced breast cancer, as an alternative treatment to the rise of estrogens. It has a similarity to trenbolone, with an enormous androgenic/anabolic ratio. Its effectiveness is so high,

FLUOXYMESTERONE

FLUOXYMESTERONE

The hepatotoxic fluoxymesterone (halotestin) is a testosterone’s derivative, highly androgenic (eight times more than testosterone) and anabolic as well. It is ideal for sports, dealing with weight class (boxing, wrestling, bodybuilding and weightlifting). Halotestin provides enormous increase in strength, which in

METHANDROSTENOLONE – METHANDIENONE

METHANDROSTENOLONE – METHANDIENONE

METHANDROSTENOLONE – METHANDIENONE Methandrostenolone – methandienone (dianabol) is a derivative of methyl-testosterone. Methandienone aromatises and the administration of an anti-estrogenic agent is necessary (anastrozole-letrozole-exemestane or tamoxifen-mesterolone), in order to avoid gynecomastia, or the retention of water and lipogenesis-fat storage. The edema